| Dr Douglas A Stahura, DO | |
|
755 Medical Park Dr, Aiken, SC 29801-6306 | |
| (803) 648-0718 | |
| (803) 641-9143 |
| Full Name | Dr Douglas A Stahura |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 26 Years |
| Location | 755 Medical Park Dr, Aiken, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467416487 | NPI | - | NPPES |
| 7522575 | Other | SC | AETNA PROVIDER NUMBER |
| 007218 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 721 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Usrc North Aiken, Llc | Aiken, SC | Dialysis facility |
| Usrc South Aiken, Llc | Aiken, SC | Dialysis facility |
| Dca Barnwell | Barnwell, SC | Dialysis facility |
| Regency Southerncare | Aiken, SC | Hospice |
| Aiken Regional Medical Center | Aiken, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Csra Renal Services, Llc | 1254323660 | 3 |
News Archive
Revive, a national public relations firm specializing in Health Care and Healthy Living, today released the results of its fourth annual National Payor Survey of hospital executives. The only one of its kind in the country, the survey targeted hospital leaders in the industry who negotiate managed care contracts with national health insurance companies - CEOs, CFOs, and directors of managed care. Participants represent 24% of hospitals in the U.S., up from 18% last year.
A scientist at Barrow Neurological Institute in Phoenix has been awarded a major grant from the Muscular Dystrophy Association to continue his groundbreaking work in the disease of myasthenia gravis.
Early results from the EuroAction hospital project, announced today at the European Society of Cardiology, demonstrate how a nurse-led multidisciplinary programme, organised in busy general hospitals, can help coronary patients and their families to reduce their risk of major cardiovascular disease (CVD).
A combination therapy of ivosenidib (IVO) plus venetoclax (VEN) with or without azacitidine (AZA) was found to be effective against a specific genetic subtype of acute myeloid leukemia (AML) in a Phase Ib/II trial led by researchers at The University of Texas MD Anderson Cancer Center.
Federal officials have asked the National Science Advisory Board for Biosecurity (NSABB) "to review the state of the science looking at human transmission of deadly bird flu, says panel chief Paul Keim of Northern Arizona University," USA Today reports.
› Verified 3 days ago
| Entity Name | Csra Renal Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295799641 PECOS PAC ID: 1254323660 Enrollment ID: O20040402000851 |
News Archive
Revive, a national public relations firm specializing in Health Care and Healthy Living, today released the results of its fourth annual National Payor Survey of hospital executives. The only one of its kind in the country, the survey targeted hospital leaders in the industry who negotiate managed care contracts with national health insurance companies - CEOs, CFOs, and directors of managed care. Participants represent 24% of hospitals in the U.S., up from 18% last year.
A scientist at Barrow Neurological Institute in Phoenix has been awarded a major grant from the Muscular Dystrophy Association to continue his groundbreaking work in the disease of myasthenia gravis.
Early results from the EuroAction hospital project, announced today at the European Society of Cardiology, demonstrate how a nurse-led multidisciplinary programme, organised in busy general hospitals, can help coronary patients and their families to reduce their risk of major cardiovascular disease (CVD).
A combination therapy of ivosenidib (IVO) plus venetoclax (VEN) with or without azacitidine (AZA) was found to be effective against a specific genetic subtype of acute myeloid leukemia (AML) in a Phase Ib/II trial led by researchers at The University of Texas MD Anderson Cancer Center.
Federal officials have asked the National Science Advisory Board for Biosecurity (NSABB) "to review the state of the science looking at human transmission of deadly bird flu, says panel chief Paul Keim of Northern Arizona University," USA Today reports.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Douglas A Stahura, DO 755 Medical Park Dr, Aiken, SC 29801-6306 Ph: (803) 648-0718 | Dr Douglas A Stahura, DO 755 Medical Park Dr, Aiken, SC 29801-6306 Ph: (803) 648-0718 |
News Archive
Revive, a national public relations firm specializing in Health Care and Healthy Living, today released the results of its fourth annual National Payor Survey of hospital executives. The only one of its kind in the country, the survey targeted hospital leaders in the industry who negotiate managed care contracts with national health insurance companies - CEOs, CFOs, and directors of managed care. Participants represent 24% of hospitals in the U.S., up from 18% last year.
A scientist at Barrow Neurological Institute in Phoenix has been awarded a major grant from the Muscular Dystrophy Association to continue his groundbreaking work in the disease of myasthenia gravis.
Early results from the EuroAction hospital project, announced today at the European Society of Cardiology, demonstrate how a nurse-led multidisciplinary programme, organised in busy general hospitals, can help coronary patients and their families to reduce their risk of major cardiovascular disease (CVD).
A combination therapy of ivosenidib (IVO) plus venetoclax (VEN) with or without azacitidine (AZA) was found to be effective against a specific genetic subtype of acute myeloid leukemia (AML) in a Phase Ib/II trial led by researchers at The University of Texas MD Anderson Cancer Center.
Federal officials have asked the National Science Advisory Board for Biosecurity (NSABB) "to review the state of the science looking at human transmission of deadly bird flu, says panel chief Paul Keim of Northern Arizona University," USA Today reports.
› Verified 3 days ago
Kate Barrett Mayes, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 223 Park Ave Se, Aiken, SC 29801 Phone: 803-641-1270 Fax: 803-641-1276 | |
Thomas Mccullough, Nephrology Medicare: Accepting Medicare Assignments Practice Location: 410 University Pkwy Ste 2500, Aiken, SC 29801 Phone: 803-648-7888 Fax: 803-648-3302 | |
Ghulam Murtaza, Nephrology Medicare: Medicare Enrolled Practice Location: 137 Miracle Dr, Aiken, SC 29801 Phone: 803-641-4874 | |
Janet L Utz, MD Nephrology Medicare: Medicare Enrolled Practice Location: 137 Miracle Drive, Aiken, SC 29801 Phone: 803-641-4874 Fax: 803-641-0436 | |
Keifer Dewayne Richardson, PA-C Nephrology Medicare: Medicare Enrolled Practice Location: 526 Richland Ave W, Aiken, SC 29801 Phone: 803-648-3130 | |
Dr. Weems R Pennington Iii, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 137 Miracle Dr, Aiken, SC 29801 Phone: 803-641-4874 Fax: 803-641-0436 | |
Dr. Frank Joseph Mondschein, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 102 Summerwood Way, Aiken, SC 29803 Phone: 803-649-5300 Fax: 803-649-0056 |